olivLaw · US equity research
The Procter & Gamble Company PG
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · SIC 2840 · Vertical: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (SIC 2840)
Procter & Gamble is a global consumer goods group whose products are sold in about 180 countries and territories, and in the first quarter of fiscal 2027 net sales reached 23.3 billion dollars. Organic sales growth of 4% and core EPS of 2.00 dollars show solid execution, but the company also confirmed a sizeable commodity cost headwind for the full year.
At the close of 04 Nov 2026, The Procter & Gamble Company (PG) stock was 167.32 USD (+3.25% on the day), with market capitalisation 387.8 bn USD, P/E 25.2 on diluted EPS of 6.64 USD over the last 12 months, dividend yield 2.56%, beta 0.09, 52-week range 138.04–167.32 USD. Latest reported quarter (Q1 2027): revenue of 23.3 bn USD (+4.0% YoY), net income of 4.7 bn USD (−0.4% YoY), diluted EPS 1.97 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 68.4
- strong (55–70)
- Bollinger (20, 2)
- 150.07 – 167.33
- in the upper half of the band · %B 1.00 · band width 10.9%
- SMA 50 / 200
- 151.11 / 149.21
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 3.81 / 3.46
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +14.6% | −1.1% | +15.7 pp | — |
| 3 months | +14.0% | −0.5% | +14.4 pp | — |
| 6 months | +13.1% | +4.4% | +8.7 pp | — |
| Year to date | +16.8% | +12.3% | +4.4 pp | — |
| 1 year | +13.7% | +13.5% | +0.1 pp | +6.3% |
| 3 years | +11.5% | +76.4% | −64.9 pp | +15.9% |
| 5 years | +14.6% | +63.7% | −49.1 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q1 2027 · 30 Sept 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.9 bn | 19.8 bn | 20.9 bn | 22.4 bn | 22.2 bn | 21.2 bn | 21.2 bn | 23.3 bn |
| Cost of revenue | 10.4 bn | 9.7 bn | 10.6 bn | 10.9 bn | 10.8 bn | 10.7 bn | 10.9 bn | 11.7 bn |
| SG&A | 5.7 bn | 5.5 bn | 5.9 bn | 5.6 bn | 6.0 bn | 5.9 bn | 6.3 bn | 5.7 bn |
| Operating income | 5.7 bn | 4.6 bn | 4.4 bn | 5.9 bn | 5.4 bn | 4.6 bn | 4.0 bn | 5.9 bn |
| Depreciation & amortisation | 706.0 m | 690.0 m | 723.0 m | 761.0 m | 803.0 m | 785.0 m | 812.0 m | 810.0 m |
| Interest expense | 240.0 m | 217.0 m | 212.0 m | 197.0 m | 220.0 m | 223.0 m | 236.0 m | 223.0 m |
| Income tax | 1.2 bn | 868.0 m | 895.0 m | 1.3 bn | 1.1 bn | 1.0 bn | 852.0 m | 1.3 bn |
| Net income | 4.6 bn | 3.8 bn | 3.6 bn | 4.8 bn | 4.3 bn | 3.9 bn | 3.0 bn | 4.7 bn |
| Diluted EPS | 1.88 | 1.54 | 1.48 ≈ | 1.95 | 1.78 | 1.63 | 1.26 ≈ | 1.97 |
| Operating cash flow | — | 3.7 bn ≈ | 5.0 bn | 5.4 bn | 5.0 bn ≈ | 4.0 bn ≈ | 5.1 bn | 5.8 bn |
| Capex | — | 859.0 m ≈ | 996.0 m | 1.2 bn | 1.2 bn ≈ | 1.0 bn ≈ | 1.0 bn | 1.4 bn |
| Dividends paid | — | 2.4 bn ≈ | 2.6 bn | 2.5 bn | 2.5 bn ≈ | 2.5 bn ≈ | 2.6 bn | 2.6 bn |
| Share repurchases | — | 1.4 bn ≈ | 700.0 m | 1.3 bn | 2.3 bn ≈ | 625.0 m ≈ | 875.0 m | 1.3 bn |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 60 percentile of its own 40-quarter history (min 15.3, median 24.6, max 82.9; quarters with earnings only).
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 67.7 bn | 71.0 bn | 76.1 bn | 80.2 bn | 82.0 bn | 84.0 bn | 84.3 bn | 87.0 bn |
| Revenue YoY | +1.3% | +4.8% | +7.3% | +5.3% | +2.3% | +2.5% | +0.3% | +3.3% |
| Net income | 3.9 bn | 13.0 bn | 14.3 bn | 14.7 bn | 14.7 bn | 14.9 bn | 16.0 bn | 16.0 bn |
| Net income YoY | −60.0% | +234.3% | +9.8% | +3.0% | −0.6% | +1.5% | +7.4% | +0.5% |
| Diluted EPS | 1.43 | 4.96 | 5.50 | 5.81 | 5.90 | 6.02 | 6.51 | 6.62 |
| Diluted EPS YoY | −61.0% | +246.9% | +10.9% | +5.6% | +1.5% | +2.0% | +8.1% | +1.7% |
| net % | 5.8% | 18.4% | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% | 18.4% |
| Free cash flow | 11.9 bn | 14.3 bn | 15.6 bn | 13.6 bn | 13.8 bn | 16.5 bn | 14.0 bn | 15.1 bn |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2026 · 30 Jun 2026
- Cash
- 9.9 bn USD
- Financial debt
- 34.1 bn USD
- Net debt
- 24.2 bn USD
- Equity
- 54.3 bn USD
- Total assets
- 126.5 bn USD
- Debt / equity
- 0.63x
- Current ratio
- 0.68x
- ROE
- 30.1%
- ROA
- 12.7%
- FCF margin
- 17.4%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 76.1 bn | 80.2 bn | 82.0 bn | 84.0 bn | 84.3 bn | 87.0 bn | SEC (XBRL)· 04 Aug 2026verified |
| Cost of revenue | 37.1 bn | 42.2 bn | 42.8 bn | 40.8 bn | 41.2 bn | 43.4 bn | SEC (XBRL)· 04 Aug 2026verified |
| Gross profit | 39.0 bn ≈ | 38.0 bn ≈ | 39.2 bn ≈ | 43.2 bn ≈ | 43.1 bn ≈ | 43.7 bn ≈ | SEC (XBRL)· 04 Aug 2026derived |
| Research & development | 1.9 bn | 2.0 bn | 2.0 bn | 2.0 bn | 2.1 bn | 2.1 bn | SEC (XBRL)· 04 Aug 2026verified |
| SG&A | 21.0 bn | 20.2 bn | 21.1 bn | 23.3 bn | 22.7 bn | 23.9 bn | SEC (XBRL)· 04 Aug 2026verified |
| Operating income | 18.0 bn | 17.8 bn | 18.1 bn | 18.5 bn | 20.5 bn | 19.7 bn | SEC (XBRL)· 04 Aug 2026verified |
| Depreciation & amortisation | 2.7 bn | 2.8 bn | 2.7 bn | 2.9 bn | 2.8 bn | 3.2 bn | SEC (XBRL)· 04 Aug 2026verified |
| EBITDA | 20.7 bn ≈ | 20.6 bn ≈ | 20.8 bn ≈ | 21.4 bn ≈ | 23.3 bn ≈ | 22.9 bn ≈ | SEC (XBRL)· 04 Aug 2026derived |
| Interest expense | 502.0 m | 439.0 m | 756.0 m | 925.0 m | 907.0 m | 877.0 m | SEC (XBRL)· 04 Aug 2026verified |
| Pre-tax income | — | 18.0 bn | 18.4 bn | 18.8 bn | 20.2 bn | 20.4 bn | SEC (XBRL)· 04 Aug 2026verified |
| Income tax | 3.3 bn | 3.2 bn | 3.6 bn | 3.8 bn | 4.1 bn | 4.2 bn | SEC (XBRL)· 04 Aug 2026verified |
| Net income | 14.3 bn | 14.7 bn | 14.7 bn | 14.9 bn | 16.0 bn | 16.0 bn | SEC (XBRL)· 04 Aug 2026verified |
| Diluted EPS | 5.50 | 5.81 | 5.90 | 6.02 | 6.51 | 6.62 | SEC (XBRL)· 04 Aug 2026verified |
| Weighted average diluted shares | 2.6 bn | 2.5 bn | 2.5 bn | 2.5 bn | 2.5 bn | 2.4 bn | SEC (XBRL)· 04 Aug 2026verified |
| Dividend per share | 3.24 | 3.52 | 3.68 | 3.83 | 4.08 | 4.26 | SEC (XBRL)· 04 Aug 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue; Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 10.3 bn | 7.2 bn | 8.2 bn | 9.5 bn | 9.6 bn | 9.9 bn | SEC (XBRL)· 04 Aug 2026verified |
| Receivables | 4.7 bn | 5.1 bn | 5.5 bn | 6.1 bn | 6.2 bn | 6.1 bn | SEC (XBRL)· 04 Aug 2026verified |
| Inventories | 6.0 bn | 6.9 bn | 7.1 bn | 7.0 bn | 7.6 bn | 8.2 bn | SEC (XBRL)· 04 Aug 2026verified |
| Current assets | 23.1 bn | 21.7 bn | 22.6 bn | 24.7 bn | 25.4 bn | 26.2 bn | SEC (XBRL)· 04 Aug 2026verified |
| Property, plant & equipment, net | 21.7 bn | 21.2 bn | 21.9 bn | 22.2 bn | 23.9 bn | 25.4 bn | SEC (XBRL)· 04 Aug 2026verified |
| Goodwill | 40.9 bn | 39.7 bn | 40.7 bn | 40.3 bn | 41.7 bn | 41.3 bn | SEC (XBRL)· 04 Aug 2026verified |
| Intangibles (excl. goodwill) | 23.6 bn | 23.7 bn | 23.8 bn | 22.0 bn | 21.9 bn | 21.4 bn | SEC (XBRL)· 04 Aug 2026verified |
| Total assets | 119.3 bn | 117.2 bn | 120.8 bn | 122.4 bn | 125.2 bn | 126.5 bn | SEC (XBRL)· 04 Aug 2026verified |
| Accounts payable | 13.7 bn | 14.9 bn | 14.6 bn | 15.4 bn | 15.2 bn | 16.3 bn | SEC (XBRL)· 04 Aug 2026verified |
| Short-term debt | 8.9 bn | 8.6 bn | 10.2 bn | 7.2 bn | 9.5 bn | 11.3 bn | SEC (XBRL)· 04 Aug 2026verified |
| Long-term debt | 23.1 bn | 22.8 bn | 24.4 bn | 25.3 bn | 25.0 bn | 22.8 bn | SEC (XBRL)· 04 Aug 2026verified |
| Current liabilities | 33.1 bn | 33.1 bn | 35.8 bn | 33.6 bn | 36.1 bn | 38.7 bn | SEC (XBRL)· 04 Aug 2026verified |
| Total liabilities | 72.7 bn | 70.4 bn | 73.8 bn | 71.8 bn | 72.9 bn | 72.2 bn | SEC (XBRL)· 04 Aug 2026verified |
| Equity | 46.7 bn | 46.9 bn | 47.1 bn | 50.6 bn | 52.3 bn | 54.3 bn | SEC (XBRL)· 04 Aug 2026verified |
Cash flow · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.4 bn | 16.7 bn | 16.8 bn | 19.8 bn | 17.8 bn | 19.6 bn | SEC (XBRL)· 04 Aug 2026verified |
| Capex | 2.8 bn | 3.2 bn | 3.1 bn | 3.3 bn | 3.8 bn | 4.4 bn | SEC (XBRL)· 04 Aug 2026verified |
| Free cash flow | 15.6 bn ≈ | 13.6 bn ≈ | 13.8 bn ≈ | 16.5 bn ≈ | 14.0 bn ≈ | 15.1 bn ≈ | SEC (XBRL)· 04 Aug 2026derived |
| Investing cash flow | -2.8 bn | -4.4 bn | -3.5 bn | -3.5 bn | -3.8 bn | -4.6 bn | SEC (XBRL)· 04 Aug 2026verified |
| Financing cash flow | -21.5 bn | -14.9 bn | -12.1 bn | -14.9 bn | -14.0 bn | -14.5 bn | SEC (XBRL)· 04 Aug 2026verified |
| Dividends paid | 8.3 bn | 8.8 bn | 9.0 bn | 9.3 bn | 9.9 bn | 10.2 bn | SEC (XBRL)· 04 Aug 2026verified |
| Share repurchases | 11.0 bn | 10.0 bn | 7.4 bn | 5.0 bn | 6.5 bn | 5.0 bn | SEC (XBRL)· 04 Aug 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 53 / 100
A scoring methodology on indicators and valuation, not investment advice.
(margin_of_safety <= -0.25 & agreement in ['high', 'medium'])
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 387.8 bn USD
Key indicators
Coverage and freshness
Score by group
- Valuation22
- Returns64
- Quality94
- Balance sheet73
- Growth21
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 55.97 – 131.03 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)80.33 – 131.03 (Mid 99.76)WACC 8.9% · starting FCFF 16.1 bn USD · terminal value share of EV 74%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 24.3%
- Peers: EV/EBITDAunavailable · not enough peers
- Peers: P/Eunavailable · not enough peers
- Dividend discount (DDM)55.97 – 75.27 (Mid 64.20)
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Unattractive profile · Score 53/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 20.0% | 100 (on a fixed band) | 10% |
| Net margin · Quality | 18.2% | 83 (vs peers) | 6% |
| FCF conversion · Quality | 95.7% | 94 (on a fixed band) | 6% |
| Revenue CAGR 3Y · Growth | 2.0% | 17 (on a fixed band) | 8% |
| EPS CAGR 3Y · Growth | 3.9% | 26 (on a fixed band) | 8% |
| Net debt / EBITDA · Balance sheet | 1.0x | 85 (on a fixed band) | 10% |
| Interest coverage · Balance sheet | 22.0x | 100 (on a fixed band) | 6% |
| Current ratio · Balance sheet | 0.7x | 0 (on a fixed band) | 4% |
| P/E (TTM) · Valuation | 25.2x | 22 (on a fixed band) | 10% |
| EV/EBITDA · Valuation | 17.9x | 0 (on a fixed band) | 10% |
| FCF yield · Valuation | 4.0% | 49 (on a fixed band) | 8% |
| Shareholder yield (distributions) · Returns | 3.9% | 56 (on a fixed band) | 6% |
| Payout ratio (FCF) · Returns | 67.1% | 76 (on a fixed band) | 4% |
Score groups
- Balance sheet73/100 · 3/3 factors with a value
- Growth21/100 · 2/2 factors with a value
- Quality94/100 · 3/3 factors with a value
- Returns64/100 · 2/2 factors with a value
- Valuation22/100 · 3/3 factors with a value
Memo
PROCTER & GAMBLE Co (PG). Latest full fiscal year: 2026; data up to 2026-09-30.
Figures computed from the financial statements: revenue 87.0 bn USD in 2026; YoY growth 3.3%; net margin 18.2%; ROE 29.4%; net debt/EBITDA 1.0x.
The estimated value range is 68.15–103.15 USD per share (median of 2 methods, agreement: high); assumptions are illustrative. Against the central value of 81.98 USD, the price of 167.32 USD leaves a potential of -51.0% (value / price − 1) and a margin of safety of -104.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 53/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 20.0%
- Net margin: 18.2%
- FCF conversion: 95.7%
- Net debt / EBITDA: 1.0x
- Interest coverage: 22.0x
- Payout ratio (FCF): 67.1%
What contradicts it
- Revenue CAGR 3Y: 2.0%
- EPS CAGR 3Y: 3.9%
- Current ratio: 0.7x
- P/E (TTM): 25.2x
- EV/EBITDA: 17.9x
- The price is above the estimated value range
Versus the vertical median
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (SIC 2840) · same industry (4-digit SIC) · compared with 6 companies
The size band was not applied: too few companies would have remained; the vertical includes much smaller or larger companies.
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| PGPROCTER & GAMBLE Co | 387.8 bn | 25.2 | 29.4% | 18.2% | +3.3% | +14% / +11% |
| ECLEcolab Inc. | 88.4 bn | 42.9 | 20.7% | 12.0% | +2.2% | +14% / +64% |
| CHDChurch & Dwight Co., Inc. | 26.4 bn | 34.5 | 17.8% | 12.4% | +1.6% | +32% / +16% |
| SCLStepan Company | 1.6 bn | 374.7 | 0.4% | 0.2% | +7.0% | +56% / −14% |
| BYAHPark Ha Biological Technology Co., Ltd. | 56.5 m | — | -885.8% | -965.0% | +6.0% | −98% / unavailable |
| WNWMeiwu Technology Company Limited | 30.8 m | — | -34.2% | -262.5% | +4,368.0% | −98% / −100% |
| ULUnilever PLC | — | — | 53.3% | 18.7% | −3.8% | −2% / +25% |
1- and 3-year price returns: for PG from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 100.38 Total return -38% · Per year -38% | 177.68 Total return 9% · Per year 9% | 267.93 Total return 63% · Per year 63% |
| 3 years | 92.59 Total return -39% · Per year -15% | 184.86 Total return 19% · Per year 6% | 306.77 Total return 94% · Per year 25% |
| 5 years | 85.40 Total return -39% · Per year -10% | 192.34 Total return 29% · Per year 5% | 351.24 Total return 129% · Per year 18% |
- Exit P/E± 46.22
- Net margin± 32.35
- Annual revenue growth± 27.21
- Annual dilution± 2.72
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Procter & Gamble is a global consumer goods group whose products are sold in about 180 countries and territories, and in the first quarter of fiscal 2027 net sales reached 23.3 billion dollars 3. Organic sales growth of 4% 3 and core EPS of 2.00 dollars 3 show solid execution, but the company also confirmed a sizeable commodity cost headwind for the full year 3.
SWOT
Strengths
- A portfolio of leading brands in many categories, with strong market positions and a global distribution network.
- Capacity to invest in innovation, research and marketing, supported by continued productivity.
- Strong cash generation that funds dividends and share repurchase programs.
Weaknesses
- Reliance on a few large customers, especially one retail chain that represents a major share of sales.
- Exposure to currency and raw material costs that can compress margins in periods of inflation.
- Ongoing restructuring and headcount reduction that can bring costs and operational strain.
Opportunities
- Growth in digital commerce and direct-to-consumer sales could open new avenues for expansion.
- Acquisitions such as Thorne could extend the portfolio into segments with growth potential.
- Emerging markets could support growth if consumer spending in those regions rises.
Threats
- Competition from private-label brands and discount competitors could pressure prices and margins.
- Geopolitical tensions and new tariffs could disrupt supply chains and export markets.
- Changes in tax and regulatory policy across several countries could raise compliance costs.
Risks
- High commodity and energy costshigh
The company anticipates a significant cost burden from raw materials, energy and transport in fiscal 2027, which could reduce profitability if not offset by pricing 3.
- Currency exposurehigh
Sales made outside the US in many currencies can be affected by exchange rate movements and by currency controls in some countries 1.
- Customer concentrationmedium
Dependence on a small number of large distributors can give them negotiating power over prices and payment terms 1.
- Geopolitical and trade tensionsmedium
Conflicts in Eastern Europe and the Middle East, sanctions and tariffs could disrupt production, distribution and access to certain markets 1.
- Credit access and ratingslow
A downgrade of the credit rating or disruption in financial markets could raise borrowing costs and reduce financial flexibility 1.
Investment thesis
What would need to be true (bull case)
- Dominant brands in many categories and the ability to support pricing through innovation could sustain organic growth if the first quarter trend continues 3.
- Strong cash generation leaves room for dividends and share repurchases, which could appeal to income-oriented shareowners 3.
- The Thorne acquisition and expansion in digital channels could add new growth if integration proceeds as planned 3.
What would break the thesis
- Higher raw material and energy costs could compress margins and limit room to invest in marketing and innovation 3.
- Competition from private-label and discount brands could force price concessions that lower returns 1.
- If geopolitical and currency tensions intensify, sales outside the US could come in weaker than management expects 1.
What to watch
- Development of raw material costs and their effect on marginsQ2 2027
- Contribution of the Thorne acquisition to total salesQ2 2027
- Delivery against organic sales and core EPS guidancefiscal 2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
The business model relies on innovation, research, brand marketing and continued productivity to fund new products and promotion 1. The company is organized into five sector business units and five reportable segments 1. More than 50% of net sales come from outside the United States 1, so results depend on currency movements.
In the first quarter of fiscal 2027 the company updated its all-in sales guidance to reflect the Thorne acquisition, effective October 1, 2026 3. Organic sales guidance was maintained, and the plan to return cash to shareowners remains substantial 3.
Segments
Fabric & Home Care
This is the largest segment, at about 35% of fiscal 2026 net sales, with brands such as Tide, Ariel, Downy and Cascade 1. The company holds a global leading position with over 35% market share in fabric care in the markets where it competes 1. In the quarter ended September 30, 2026, segment organic sales rose 5% 3.
Market context
The consumer goods market is highly competitive, with global, regional and local competitors as well as retailers' private-label brands 1. The company competes in segments differentiated by price tiers, from super-premium to value, and says it often holds a leadership or significant share position 1. Cost pressures from raw materials, energy and transport can affect margins if they are not offset by pricing and productivity 3.
Sales channels are shifting quickly toward online, social commerce and hard discount stores, which could change consumer preferences and market structure 1. The company says it is responding through innovation and by adapting its distribution model 1.
Trends
- Rising raw material costsheadwind
The company expects a commodity cost headwind of about 1.4 billion dollars after tax in fiscal 2027 3. This could reduce margins if prices cannot be passed on fully to customers 3.
- Digital commerce and new channelsmixed
Growing consumer preference for online and social shopping is changing distribution and marketing 1. If the company adapts quickly, this shift could support sales over the longer term 1.
- Thorne acquisitionmixed
The Thorne acquisition, effective October 1, 2026, could add sales in fiscal 2027, and all-in sales guidance was adjusted accordingly 3. Integrating an acquisition can also bring operational risks 1.
- Geopolitical and currency tensionsheadwind
The war between Russia and Ukraine, tensions in the Middle East and currency swings can affect sales, costs and cash flows 1. More than half of sales come from outside the US, which makes currency exposure significant 1.
Competitive position
The company competes with global and local competitors in each category, as well as with retailers' private-label brands 1. Competition centers on prices, promotions, trade terms and innovation, and entry into digital channels is easier for rivals 1. The company says it maintains leading positions through product and brand superiority 1.
Differentiation depends on keeping market positions against lower-priced products and the growth of discount channels 1. Failing to anticipate these shifts could affect results, according to the company's own risk disclosures 1.
- Unilever
Global competitor in personal care, home care and food, named among the company's global rivals in its filings.
- Colgate-PalmoliveCL
Competitor in oral care and household products, among the company's global rivals.
- Kimberly-ClarkKMB
Competitor in paper and diaper categories, relevant to the family and baby care lines.
- Retailers' private-label brands
Store-branded products that compete directly with the company's brands across several categories.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Două noi săli de clasă, renovate pentru elevii claselor pregătitoare din Alba și Giurgiu, cu ajutorul dm și P&GLibertatea.ro · 05 Nov 2026 · RO
- Award-winning research helps companies keep products where they're needed mostPhys.org · 30 Oct 2026 · EN
- PepsiCo, Nestlé, Coca-Cola și alte zece companii lansează Asociația Română a Produselor de Marcă. Ce își propune noua organizațieEconomedia · 30 Oct 2026 · RO
- Santoli: We are nearing a now-or-never moment for the AI trade to reboundCNBC — Top News · 27 Oct 2026 · EN
- Dow Jones завершил торги в небольшом плюсе, Nasdaq упал максимально с июняInterfax Russia (RU) · 23 Oct 2026 · RU
- Americans are having fewer babies — and pampering them with luxury diapersMarketWatch — Top Stories · 22 Oct 2026 · EN
- Stocks making the biggest moves midday: Procter & Gamble, Lam Research, Blackstone, Southwest & moreCNBC — Top News · 22 Oct 2026 · EN
- Spotify Rallies on Subscribers; Hermès falls on China Sales | Stock MoversBloomberg Markets · 22 Oct 2026 · EN
- Contractele futures pe acțiunile din SUA scad, pe fondul pierderilor din sectorul tehnologic și al tensiunilor cu Iranul care tulbură piețele - Traders UnionSurge — Google News · 22 Oct 2026 · RO
- Procter & Gamble earnings beat as sales rise 4%, boosted by laundry and home productsCNBC — Top News · 22 Oct 2026 · EN
- Viitoarele bursiere americane scad după rezultatele trimestriale ale Meta și Tesla - www.goldring.roSurge — Google News · 21 Oct 2026 · RO
- Why Investors May Want to Buy Procter & Gamble if Consumer Spending CoolsYahoo Finance — News · 17 Sept 2026 · EN
- Jim Cramer Discusses Procter & Gamble (PG) Valuation and GrowthYahoo Finance — News · 07 Sept 2026 · EN
- Which Defensive Stock Has Dominated in 2026: Coca-Cola, Johnson & Johnson, or Procter & Gamble?Yahoo Finance — News · 07 Sept 2026 · EN
- 1 Stat That Makes Procter & Gamble Hard to Ignore This SeptemberYahoo Finance — News · 07 Sept 2026 · EN
- Here's How Many Shares of Procter & Gamble You'd Need for $15,000 in Yearly DividendsYahoo Finance — News · 05 Sept 2026 · EN
- The Best Dividend Stock for 2027 and Beyond: Procter & GambleYahoo Finance — News · 31 Aug 2026 · EN
- Is Procter & Gamble Stock Underperforming the Nasdaq?Yahoo Finance — News · 29 Aug 2026 · EN
- CEC Bank pentru afaceri româneşti, un proiect ZF şi CEC Bank. Ştefan Tudos, vicepreşedinte, Genesis Property: Piaţa de birouri e stabilă şi cu tendinţă de creştere. Nu mai vorbim de costul pe workstation, ci de angajat, iar chiriile reflectă calitatea proiectului. Genesis Property a semnat în primul semestru cu Procter & Gamble şi a prelungit contracte în YUNITY ParkZiarul Financiar · 11 Aug 2026 · RO
- Procter & Gamble will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBCCNBC World · 04 Aug 2026 · EN
SEC filings
- Current report03 Nov 2026Other events · Financial statements and exhibits
- Current report02 Nov 2026Other events · Financial statements and exhibits
- Current report30 Oct 2026Other events · Financial statements and exhibits
- Quarterly report22 Oct 2026
- Current report22 Oct 2026Regulation FD disclosure · Financial statements and exhibits
- Current report22 Oct 2026Results of operations · Financial statements and exhibits
- Current report16 Oct 2026Shareholder vote
- Current report13 Oct 2026Regulation FD disclosure · Financial statements and exhibits
- Proxy statement28 Aug 2026
- Annual report04 Aug 2026
Sources
- [1] Form 10-K, fiscal year ended 2026-06-30 · SEC / The Procter & Gamble Company · 04 Aug 2026
- [2] Form 10-Q, quarter ended 2026-09-30 · SEC / The Procter & Gamble Company · 22 Oct 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / The Procter & Gamble Company · 22 Oct 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.